1. Tice AD, Rehm SJ, Dalovisio JR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy: IDSA guidelines. Clin Infect Dis 2004; 38:1651–1672.
2. Chapman ALN. Outpatient parenteral antimicrobial therapy. BMJ 2013;346:f1585
3. Paladino JA, Poretz D. Outpatient Parenteral Antimicrobial Therapy Today. CID 2010; 51(S2):198–208
4. Norris AH, Shrestha NK, Allison GM, et al. 2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy: Clin
Infect Dis. 2019;68(1):e1.
5. DeMaio J. Outpatient parenteral antibiotic therapy. Infect Med 2004;21(10):496-504.
6. Eaton EF, Mathews RE, Lane PS, et al. A 9-Point Risk Assessment for Patients Who Inject Drugs and Require Intravenous Antibiotics: Focusing Inpatient Resources on Patients at Greatest
Risk of Ongoing Drug Use. Clin Infect Dis. 2019;68(6):1041.
7. Shrestha NK, Shrestha J, Everett A, et al. Vascular access complications during outpatient parenteral antimicrobial therapy at home: a retrospective cohort study. J Antimicrob Chemother.
2016;71(2):506. Epub 2015 Oct 28.
8. Ho J, Archuleta S, Sulaiman Z, Fisher D.J Safe and successful treatment of intravenous drug users with a peripherally inserted central catheter in an outpatient parenteral antibiotic treatment
service. Antimicrob Chemother. 2010;65(12):2641.
9. D’Couto HT, Robbins GK, Ard KL, Wakeman SE, Alves J, Nelson SB.Outcomes According to Discharge Location for Persons Who Inject Drugs Receiving Outpatient Parenteral Antimicrobial
Therapy. Open Forum Infect Dis. 2018;5(5):056.
10. Beieler A, Magaret A, Zhou Y, Schleyer A, Wald A, Dhanireddy S.J Outpatient Parenteral Antimicrobial Therapy in Vulnerable Populations– People Who Inject Drugs and the Homeless. Hosp
Med. 2019;14(2):105.
11. Marwick C, Broomhall J, McCowan C, et al. Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalised patients. J Antimicrob Chemo-
ther 2011;66:387-397.
12. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneu-
monia in Adults. CID 2007;44:27–72
13. Mackintosh CL, White HA, Seaton RA. Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service. J Antimicrob
Chemother 2011;66:408-415.
14. Esposito S, Leone S, Noviello S, et al. Outpatient parenteral antibiotic therapy for bone and joint infections: an Italian multicenter study, J Chemother 2007;19:417-422.
15. Gould FK, Denning DW, Elliott TSJ, et al. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the working party of the British Society for Antimicrobial
Chemotherapy. J Antimicrob Chemother 2012;67:269-289.
16. Perspectives of Patients on Outpatient Parenteral Antimicrobial Therapy: Experiences and Adherence.Hamad Y, Dodda S, Frank A, Beggs J, Sleckman C, Kleinschmidt G, Lane MA, Burnett
Y. Open Forum Infect Dis. 2020;7(6):ofaa205.
17. Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections. Bork JT, Heil EL, Berry S, Lopes E, DavéR, Gilliam BL,
Amoroso A.Infect Dis Ther. 2019;8(2):171.
18. Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care. Ajaka L, Heil E, Schmalzle S. Antibiotics (Basel). 2020;9(10)
19. Esposito s, Noviello S, Leone S, et al. Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int J Antimicrob Agents 2004;24:473-